Reassuring data on use of blood pressure medications in COVID-19 patients

+Practice

HEARTBEAT

Reassuring data on use of blood pressure medications in COVID-19 patients

3 June 2020

Chris Ellis

Wednesday 3 June 2020, 02:03 PM

Patients might be concerned about what they read and hear in the news regarding the use of renin–angiotensin system blockers during the COVID-19 pandemic. Cardiologist Chris Ellis reviews recent research and current recommendations

Key points, A letter published in March hypothesised that ACE inhibitors and angiotensin II receptor blockers might increase the risk of developing severe and fat, Pract Green w Pale Yellow

COVID-19

Cardiovascular

Research

References

1. Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 2020;8(4):e21.
2. Zhang P, Zhu L, Cai J, et al. Association of inpatient use ofangiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res 2020; 17 April online.
3. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2224–60.

How to Treat

Prostate cancer

Prostate cancer consultations are common in primary care and there is no one approach to testing and treatment that fits all patients. Urologist Simon van Rij discusses the key considerations and options for personalised care, appropriate investigation and treatment

Wednesday 11 September 2024, 12:45 AM